Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-670
Closed -$4K 9253
2023
Q3
$4K Buy
+670
New +$5.79K ﹤0.01% 7771
2023
Q1
Sell
-235
Closed -$6.05K 9483
2022
Q4
$2K Buy
+235
New +$7.95K ﹤0.01% 8584
2022
Q3
Sell
-27
Closed -$3.72K 10333
2022
Q2
$3K Buy
+27
New +$4.06K ﹤0.01% 9148
2022
Q1
Sell
-13
Closed -$2.72K 10830
2021
Q4
$3K Buy
13
+12
+1,200% +$4.58K ﹤0.01% 9826
2021
Q3
$0 Sell
1
-2
-67% -$1.25K ﹤0.01% 9812
2021
Q2
$2K Sell
3
-92
-97% -$67.1K ﹤0.01% 9713
2021
Q1
$72K Sell
95
-4
-4% -$3.48K ﹤0.01% 6170
2020
Q4
$51K Buy
99
+97
+4,850% +$79K ﹤0.01% 6156
2020
Q3
$1K Buy
+2
New +$2.9K ﹤0.01% 7556

Other funds holding IBIO

Simplex Trading's IBIO Position: Q4 2023 in Review

Simplex Trading sold out of iBio (IBIO) in Q4 2023, closing a stake of 670 shares — an estimated $4K sold.

Simplex Trading first reported a position in IBIO in Q3 2020 and held it in 9 quarters. The position peaked at $72K in Q1 2021. 21 funds tracked by Wall St. Rank hold IBIO as of Q4 2023.

  • Simplex Trading reported no remaining iBio position as of Q4 2023 after selling out during the quarter.
  • Simplex Trading sold 670 iBio shares in Q4 2023, an estimated $4K.
  • Simplex Trading first reported a position in iBio in Q3 2020 and held it in 9 quarters.
  • Simplex Trading's iBio position peaked at $72K in Q1 2021.
  • 21 funds tracked by Wall St. Rank held iBio as of Q4 2023.

Based on Simplex Trading's 13F filing for Q4 2023, filed 2 Feb 2024.